CAFFX
Price
$44.06
Change
-$0.07 (-0.16%)
Updated
Sep 20 closing price
GFACX
Price
$66.58
Change
-$0.13 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

CAFFX vs GFACX

Header iconCAFFX vs GFACX Comparison
Open Charts CAFFX vs GFACXBanner chart's image
American Funds AMCAP 529F1
Price$44.06
Change-$0.07 (-0.16%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$66.58
Change-$0.13 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CAFFX vs GFACX Comparison Chart
Loading...
VS
CAFFX vs. GFACX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAFFX is a Buy and GFACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 290B vs. CAFFX (89.3B). CAFFX pays higher dividends than GFACX: CAFFX (0.71) vs GFACX (0.00). CAFFX was incepted earlier than GFACX: CAFFX (22 years) vs GFACX (24 years). CAFFX (31.00) and GFACX (31.00) have comparable annual turnover. CAFFX (250) and GFACX (250) have matching initial minimum investment requirements. CAFFX (28.83) and GFACX (28.04) have marching annual gain over last year. GFACX return over 5 years is better than : 45.21 vs. CAFFX (40.33).
CAFFXGFACXCAFFX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD16.00821.05576%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets89.3B290B31%
Annual Yield % from dividends0.710.00-
Returns for 1 year28.8328.04103%
Returns for 3 years1.08-3.58-30%
Returns for 5 years40.3345.2189%
Returns for 10 years59.5652.57113%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRTX1.920.26
+15.66%
BioRestorative Therapies
DBRG14.510.33
+2.33%
DigitalBridge Group
EG387.50-0.80
-0.21%
Everest Group Ltd
DLHC9.78-0.18
-1.81%
DLH Holdings Corp
TMCI5.44-0.16
-2.86%
Treace Medical Concepts